doi: 10.3389/fendo.2021.721135
The safer approach is to contact the prescribing clinician before changing the dose
The combination of structural resistance to DPP-4 and prolonged half-life via HSA fusion allows for once-weekly administration, positioning albiglutide as a viable and efficacious GLP-1 receptor agonist for long-term glycemic control [14]
Some people notice facial fat loss, temporary hair shedding, or changes linked to rapid weight loss
Weight loss results are achieved as part of a balanced, reduced-calorie diet and regular exercise program
If you experience severe symptoms like persistent vomiting, severe abdominal pain, or signs of pancreatitis (intense upper abdominal pain radiating to the back), seek medical attention immediately